The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys

Behavioral Neuroscience

Volumn 111, Issue 5, 1997, Pages 883-891

  Steere, J C ^b   Arnsten, A F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; GUANFACINE;

AGING; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; PREFRONTAL CORTEX; RHESUS MONKEY; TASK PERFORMANCE; VISUAL DISCRIMINATION;

ADRENERGIC ALPHA-AGONISTS; AGING; ANIMALS; ATTENTION; BRAIN MAPPING; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANFACINE; MACACA MULATTA; MENTAL RECALL; NOREPINEPHRINE; PATTERN RECOGNITION, VISUAL; PREFRONTAL CORTEX; RECEPTORS, ADRENERGIC, ALPHA-2; REVERSAL LEARNING;

EID: 0030730925     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.111.5.883     Document Type: Article

References (55)

1. Arnsten, A. F. T. (1997). Catecholamine regulation of prefrontal cortex. Journal of Psychopharmacology, 11, 151-162.
2. Arnsten, A. F. T., Cai, J. X., & Goldman-Rakic, P. S. (1988). The α-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: Evidence for α-2 receptor subtypes. Journal of Neuroscience, 8, 4287-4298.
3. Arnsten, A. F. T., Cai, J. X., Murphy, B. L., & Goldman-Rakic, P. S. (1994). Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology, 116, 143-151.
4. Arnsten, A. F. T., Cai, J. X., Steere, J. C., & Goldman-Rakic, P. S. (1995). Dopamine D2 receptor mechanisms contribute to agerelated cognitive decline: The effects of quinpirole on memory and motor performance in monkeys. Journal of Neuroscience, 15, 3429-3439.
5. Arnsten, A. F. T., & Contant, T. A. (1992). α-2 Adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psvchopharmacology, 108, 159-169.
6. Arnsten, A. F. T., & Goldman-Rakic, P. S. (1985, December 13). α-2 Adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged human primates. Science, 230, 1273-1276.
7. Arnsten, A. F. T., & Goldman-Rakic, P. S. (1990). Analysis of α-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys. Neurobiology of Aging, 11, 583-590.
8. Arnsten, A. F. T., & Leslie, F. M. (1991). Behavioral and receptor binding analysis of the alpha-2 adrenergic agonist UK-14304 (5 bromo-6 [2-imidazoline-2-yl amino] quinoxaline): Evidence for cognitive enhancement at an alpha-2 adrcnoceptor subtype. Neurophannacology, 30, 1279-1289.
9. Arnsten, A. F. T., Lin, C. H., van Dyck, C. H., & Stanhope, K. J. (1997). The effects of 5HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiology of Aging, 18, 21-28.
10. Arnsten, A. F. T., Steere, J. C., & Hunt, R. D. (1996). The contribution of α-2 noradrenergic mechanisms to prefrontal cortical cognitive function: Potential significance to Attention Deficit Hyperactivity Disorder. Archives of General Psychiatry, 55, 448-455.
11. Bartus, R. T., Dean, R. L., & Fleming, D. L. (1979). Aging in the rhesus monkey: Effects on visual discrimination learning and reversal learning. Journal of Gerontology, 34, 209-219.
12. Berridge, C. W., Bolen, S. J., Manley, M. S., & Foote, S. L. (1996). Modulation of forebrain elcctroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic betareceptors within the medial septal region. Journal of Neuroscience, 16, 7010-7020.
13. Berridge, C. W., & Foote, S. L. (1991). Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. Journal of Neuroscience, 11, 3135-3145.
14. Berridge, C. W., & Foote, S. L. (1996). Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. Journal of Neuroscience, 16, 6999-7009.
15. Blumer, D., & Benson, D. F. (1975). Personality changes with frontal and temporal lobe lesions. In D. F. Benson & D. Blumer (Eds.), Psychiatric aspects of neurologic disease (pp. 151-170). New York: Grune and Stratton.
16. 3H]idazoxan in rat brain. Journal of Pharmacological and Experimental Therapeutics, 241, 1092-1098.
17. Brown, C. M., MacKinnon, A. C., McGrath, J. C., Spedding, M., & Kilpatrick, A. T. (1990). α-2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. British Journal of Pharmacology, 99, 803-809.
18. Butter, C. M. (1969). Perseveration in extinction and in discrimination reversal tasks following selective frontal ablations in Macaco mulatta. Physiological Behavior, 4, 163-171.
19. Butter, C. M., Snyder, D. R., & McDonald, J. A. (1970). Effects of orbital frontal lesions on aversive and aggressive behaviors in rhesus monkeys. Journal of Comparative and Physiological Psychology, 72, 132-144.
20. Buzsaki, G., Kennedy, B., Soil, V. B., & Ziegler, M. (1991). Noradrenergic control of thalamic oscillation: The role of α-2 receptors. European Journal of Pharmacology, 3, 222-229.
21. Bylund, D. B. (1985). Heterogeneity of α-2 adrenergic receptors. Pharmacology, Biochemistry & Behavior, 22, 835-843.
22. Cai, J. X., Ma, Y., Xu, L., & Hu, X. (1993). Reserpine impairs spatial working memory performance in monkeys: Reversal by the α-2-adrenergic agonist clonidine. Brain Research,. 614, 191-196.
23. Chappell, P. B., Riddle, M. A., Scahill, L., Lynch, K., Schultz, R., Arnsten, A. F. T., Leckman, J. F., & Cohen, D. L. (1995). Guanfacine treatment of comorbid Attention Deficit Hyperactivity Disorder and Tourette's Syndrome: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1140-1146.
24. Coull, J. T. (1994). Pharmacological manipulations of the α-2 noradrenergic system: Effects on cognition. Drugs and Aging, 5, 116-126.
25. Dias, R., Robbins, T. W., & Roberts, A. C. (1996). Dissociation in prefrontal cortex of affective and attentional shifts. Nature, 380, 69-72.
26. Franowicz, J. S., & Arnsten, A. F. T. (1996). The α-2A adrenergic agonist, guanfacine, calms behavior in young monkeys. Manuscript submitted for publication.
27. Goldman-Rakic, P. S. (1987). Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. In F. Plum (Ed.), Handbook of physiology: Sect. 1. The nervous system: Vol. V. Higher functions of the brain (Pt. 1, pp. 373-417). Bethesda, MD: American Physiological Society.
28. Horrigan, J. P., & Barnhill, L. J. (1995). Guanfacine for treatment of Attention-Deficit Hyperactivity Disorder in boys. Journal of Child and Adolescent Psychophannacology, 5, 215-223.
29. Hunt, R. D., Arnsten, A. F. T., & Asbell, M. D. (1995). An open trial of guanfacine in the treatment of Attention Deficit Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 50-54.
30. Hunt, R. D., Capper, L., & O'Connell, P. (1990). Clonidine in child and adolescent psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry, 1, 87-102.
31. Iversen, S., & Mishkin, M. (1970). Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Experimental Brain Research, 11, 376-386.
32. Jackson, W. J., & Buccafusco, J. J. (1991). Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacology, Biochemistry & Behavior, 39, 79-84.
33. Kobilka, B. K., Matsui, H., Kobilka, T. S., Yang-Feng, T. L., Francke, U., Caron, M. G., Lefkowitz, R. J., Regan, J. W. (1987, October 30). Cloning, sequencing, and expression of the gene encoding for the human platelet α-2-adrenergic receptor. Science, 238, 650-656.
34. Li, B. -M., & Mei, Z.-T. (1994). Delayed response deficit induced by local injection of the α-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behavioral and Neural Biology, 62, 134-139.
35. Li, B.-M, & Mei, Z.-T. (1995). α-2 Adrenergic modulation of prefrontal neuronal activity related to working memory in monkeys. Abstracts of 3rd Congress of Federation of Asian and Oceanian Physiological Society, S9-3, 96.
36. Lomasney, J. W., Lorenz, W., Alien, L. F., King, K., Regan, J. W., Yang-Feng, T. L., Caron, M. G., & Lefkowitz, R. J. (1990). Expansion of the α-2 adrenergic family: Cloning and characterization of a human α-2-adrenergic receptor subtype, the gene for which is located on Chromosome 2. Proceedings of the National Academy of Sciences. USA, 87, 5094-5098.
37. Luria, A. R. (1966). Higher cortical functions in man. New York: Basic Books.
38. McEnaney, K. W., & Butter, C. M. (1969). Perseveration of responding and nonresponding in monkeys with orbital frontal ablations. Journal of Comparative and Physiological Psychology, 68, 558-561.
39. 3H]Idazoxan and some other α-2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Molecular Pharmacology, 35, 324-330.
40. Miller, L. A. (1992). Impulsivity, risk-taking, and the ability to synthesize fragmented information after frontal lobectomy. Neuropsychologia, 30, 69-79.
41. Mishkin, M. (1964). Perseveration of central sets after frontal lesions in monkeys. In J. M. Warren & K. Akert (Eds.), The frontal granular cortex and behavior (pp. 219-241), New York: McGraw-Hill.
42. Mishkin, M., Vest, B., Morris, M., & Rosvold, H. E. (1969). A re-examination of the effects of frontal lesions on object alternation. Neumpsychology, 7, 357-363.
43. Morecraft, R. J., Geula, C., & Mesulam, M. M. (1992). Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. Journal of Comparative Neurology, 323, 341-358.
44. Oscar-Berman, M. (1978). The effects of dorsolateral-frontal and ventrolateral-orbitofrontal lesions on nonspatial test performance. Neuropsychology, 16, 259-267.
45. Rapp, P. R. (1990). Visual discrimination and reversal learning in the aged monkey (Macaca mulatta). Behavioral Neuroscience, 104, 876-884.
46. Regan, J. W., Kobilka, T. S., Yang-Feng, T. L., Caron, M. G., Lefkowitz, R. J., & Kobilka, B. K. (1988). Cloning and expression of a human kidney cDNA for an α-2 adrenergic receptor subtype. Proceedings of the National Academy of Sciences, USA., 85, 6301-6305.
47. Ridley, R. M., Durnford, L. J., Baker, J. A., & Baker, H. F. (1993). Cognitive inflexibility after archicortical and paleocortical prefrontal lesions in marmosets. Brain Research, 628, 56-64.
48. Ruch, T. C., & Shenkin, H. A. (1943). The relation of area 13 on orbital surface of frontal lobes to hyperactivity and hyperphagia in monkeys. Journal of Neurophysiology, 5, 349-360.
49. Steere, J. C., & Arnsten, A. (1994). The alpha-2A Noradrenergic agonist, guanfacine, improves delayed response performance and calms behavior in young monkeys: Relevance to attention-deficit disorder. Society for Neuroscience Abstracts, 20, 831.
50. Steere, J. C., Li, B.-M., Jentsch, J. D., Mathew, R., Taylor, J. R., & Arnsten, A. F. T. (1996). α-1 noradrenergic stimulation impairs, while α-2 stimulation improves, prefrontal cortex spatial working memory function. Society for Neuroscience Abstracts, 22, 1126.
51. Stuss, D. T., Gow, C. A., & Hetherington, C. R. (1992). No longer Gage: Frontal lobe dysfunction and emotional changes. Journal of Consulting and Clinical Psychology 60, 349-359.
52. Stuss, D. T., Kaplan, E. F., Benson, D. F., Weir, W. S., Chiulli, S., & Sarazin, F. F. (1982). Evidence for the involvement of orbitofrontal cortex in memory functions: An interference effect. Journal of Comparative and Physiological Psychology, 96, 913-925.
53. Tanila, H., Rama, P., & Carlson, S. (1996). The effects of prefrontal intracortical microinjections of an α-2 agonist, α-2 antagonist and lidocaine on the delayed alternation performance of aged rats. Brain Research Bulletin. 40, 117-119.
54. 3H]RX821002 radioligand binding: Computer modeling reveals that guanfacine is an α-2A-selective compound. European Journal of Pharmacology, 202, 235-243.
55. Vigne, P., Lazdunski, M. & Frelin, C. (1989). Guanabenz, guanachlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes. European Journal of Pharmacology, 160, 295-298.